Free Trial

Nano-X Imaging (NNOX) Competitors

Nano-X Imaging logo
$5.13 -0.11 (-2.10%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$5.19 +0.06 (+1.25%)
As of 05/23/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NNOX vs. AORT, KMTS, PLSE, FNA, BLFS, ESTA, MDXG, INMD, SIBN, and IRMD

Should you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include Artivion (AORT), Kestra Medical Technologies (KMTS), Pulse Biosciences (PLSE), Paragon 28 (FNA), BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), InMode (INMD), SI-BONE (SIBN), and Iradimed (IRMD). These companies are all part of the "medical equipment" industry.

Nano-X Imaging vs.

Nano-X Imaging (NASDAQ:NNOX) and Artivion (NYSE:AORT) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

Nano-X Imaging received 6 more outperform votes than Artivion when rated by MarketBeat users. However, 83.33% of users gave Artivion an outperform vote while only 75.00% of users gave Nano-X Imaging an outperform vote.

CompanyUnderperformOutperform
Nano-X ImagingOutperform Votes
36
75.00%
Underperform Votes
12
25.00%
ArtivionOutperform Votes
30
83.33%
Underperform Votes
6
16.67%

Artivion has higher revenue and earnings than Nano-X Imaging. Artivion is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nano-X Imaging$11.55M25.67-$60.78M-$0.90-5.70
Artivion$390.08M3.14-$30.69M-$0.50-57.28

Nano-X Imaging has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500. Comparatively, Artivion has a beta of 1.54, indicating that its share price is 54% more volatile than the S&P 500.

In the previous week, Nano-X Imaging had 3 more articles in the media than Artivion. MarketBeat recorded 10 mentions for Nano-X Imaging and 7 mentions for Artivion. Artivion's average media sentiment score of 1.20 beat Nano-X Imaging's score of 0.54 indicating that Artivion is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nano-X Imaging
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Artivion
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Nano-X Imaging currently has a consensus price target of $9.50, suggesting a potential upside of 85.19%. Artivion has a consensus price target of $31.40, suggesting a potential upside of 9.64%. Given Nano-X Imaging's higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than Artivion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Artivion
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17

21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 86.4% of Artivion shares are held by institutional investors. 7.7% of Nano-X Imaging shares are held by insiders. Comparatively, 7.6% of Artivion shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Artivion has a net margin of -0.22% compared to Nano-X Imaging's net margin of -465.38%. Artivion's return on equity of 5.15% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Nano-X Imaging-465.38% -27.63% -24.72%
Artivion -0.22%5.15%1.91%

Summary

Artivion beats Nano-X Imaging on 12 of the 19 factors compared between the two stocks.

Get Nano-X Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NNOX vs. The Competition

MetricNano-X ImagingX IndustryBusiness SectorNASDAQ Exchange
Market Cap$296.41M$10.97B$24.30B$8.30B
Dividend YieldN/A1.66%2.63%4.11%
P/E Ratio-6.0416.5532.7519.59
Price / Sales25.677.55357.57136.01
Price / CashN/A11.9030.9334.64
Price / Book1.451.945.384.50
Net Income-$60.78M$344.53M$196.34M$248.60M
7 Day Performance-8.39%-6.77%-1.21%-0.89%
1 Month Performance-3.57%-0.24%8.69%7.72%
1 Year Performance-39.15%-7.03%18.16%8.62%

Nano-X Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NNOX
Nano-X Imaging
1.3694 of 5 stars
$5.13
-2.1%
$9.50
+85.2%
-39.1%$296.41M$11.55M-6.04190Trending News
Earnings Report
Analyst Forecast
Gap Down
AORT
Artivion
1.5456 of 5 stars
$29.53
+0.1%
$31.40
+6.3%
+20.4%$1.26B$390.08M-1,476.501,300Positive News
Insider Trade
KMTS
Kestra Medical Technologies
N/A$24.36
-1.1%
$27.50
+12.9%
N/A$1.25B$52.64M0.00300News Coverage
PLSE
Pulse Biosciences
0.711 of 5 stars
$17.28
+0.5%
N/A+48.5%$1.16B$700,000.000.00140
FNA
Paragon 28
N/A$13.11
+0.1%
$12.75
-2.7%
+67.6%$1.10B$256.18M-17.71343,000High Trading Volume
BLFS
BioLife Solutions
2.4411 of 5 stars
$22.85
-3.1%
$31.17
+36.4%
+0.3%$1.09B$87.76M-21.56440Positive News
Analyst Downgrade
Gap Down
ESTA
Establishment Labs
3.0194 of 5 stars
$36.89
+2.0%
$55.33
+50.0%
-31.6%$1.07B$170.24M-14.30960Positive News
Analyst Downgrade
Gap Down
MDXG
MiMedx Group
3.9206 of 5 stars
$7.21
+2.3%
$12.50
+73.4%
-14.5%$1.06B$352.38M13.11870Positive News
INMD
InMode
3.4339 of 5 stars
$14.48
-1.3%
$18.54
+28.1%
-23.0%$1.01B$392.41M6.16480Positive News
SIBN
SI-BONE
3.5457 of 5 stars
$19.57
-1.1%
$22.50
+15.0%
+35.6%$833.98M$176.60M-21.27350Positive News
Insider Trade
IRMD
Iradimed
4.8884 of 5 stars
$54.38
+0.9%
$72.00
+32.4%
+20.6%$691.44M$75.15M36.25110Positive News
Ex-Dividend

Related Companies and Tools


This page (NASDAQ:NNOX) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners